Clinical Trial Update: Combined Immunosuppression for Pediatric Crohn's Disease [Phase 4]

View source ↗

Summary

An ongoing Phase 4 clinical trial is evaluating combined immunosuppression for pediatric Crohn's disease using infliximab.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Children's Hospital of Fudan University | Conditions: Crohn Disease, Infliximab | Phase 4 | Status: RECRUITING